Mark R. Albertini
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 52
- Immunotherapy and Immune Responses 40
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 10
- Oncology 49
- CAR-T cell therapy research 27
- Cancer Immunotherapy and Biomarkers 22
- Co-authors
- Paul M. Sondel (38 shared papers)Jacquelyn A. Hank (30 shared papers)Jacek Gan (12 shared papers)Joan H. Schiller (17 shared papers)Stephen D. Gillies (9 shared papers)Jens C. Eickhoff (6 shared papers)Heidi Schalch (8 shared papers)Ralph A. Reisfeld (4 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Journal of Immunotherapy (11 papers)Cancer (9 papers)Clinical Cancer Research (8 papers)Cancer Immunology Immunotherapy (6 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Mark R. Albertini
93 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 91
- Immunology 1.0k
- Oncology 1.0k
- Neurology 310
- Immunology and Allergy 93
- Radiology, Nuclear Medicine and Imaging 289
Countries citing papers authored by Mark R. Albertini
This map shows the geographic impact of Mark R. Albertini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Albertini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Albertini more than expected).
Fields of papers citing papers by Mark R. Albertini
This network shows the impact of papers produced by Mark R. Albertini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Albertini. The network helps show where Mark R. Albertini may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Albertini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 183 | |
| 2 | 2006 | 132 | |
| 3 | 2008 | 130 | |
| 4 | 2008 | 119 | |
| 5 | 2004 | 114 | |
| 6 | 2009 | 106 | |
| 7 | 2005 | 103 | |
| 8 | 2007 | 79 | |
| 9 | 2012 | 65 | |
| 10 | 2007 | 59 | |
| 11 | Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. | 1997 | 59 |
| 12 | 1996 | 50 | |
| 13 | 2012 | 49 | |
| 14 | 1998 | 45 | |
| 15 | Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor. | 2001 | 42 |
| 16 | 2017 | 40 | |
| 17 | 1999 | 38 | |
| 18 | 2009 | 37 | |
| 19 | 1997 | 37 | |
| 20 | 2018 | 36 |
About Mark R. Albertini
Mark R. Albertini is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 100 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (40 papers), CAR-T cell therapy research (27 papers), Cancer Immunotherapy and Biomarkers (22 papers), Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers), Neuroblastoma Research and Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (1.0k citations), Neurology (310 citations), Immunology and Allergy (93 citations) and Radiology, Nuclear Medicine and Imaging (289 citations). Mark R. Albertini has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Paul M. Sondel, Jacquelyn A. Hank, Jacek Gan, Joan H. Schiller, Stephen D. Gillies, Jens C. Eickhoff, Heidi Schalch, Ralph A. Reisfeld, Cindy Zuleger and David M. Mahvi. Their work appears in journals such as Journal of Clinical Oncology, Journal of Immunotherapy, Cancer, Clinical Cancer Research and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.